<?xml version="1.0" encoding="UTF-8"?>
<ref id="B150-molecules-25-04036">
 <label>150.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>García</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Palomo-Garo</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>García-Arencibia</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ramos</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pertwee</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Fernández-Ruiz</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease</article-title>
  <source>Br. J. Pharm.</source>
  <year>2011</year>
  <volume>163</volume>
  <fpage>1495</fpage>
  <lpage>1506</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01278.x</pub-id>
  <?supplied-pmid 21323909?>
  <pub-id pub-id-type="pmid">21323909</pub-id>
 </element-citation>
</ref>
